Stem Cell Therapy Products | Stem Cell Therapy Applications | Corning

Introduction

Moving Stem Cell Therapy Research Forward

Moving Stem Cell Therapy Research Forward

The recognition that mesenchymal stem cells can modify immune functions has piqued interest in developing cells to treat a range of musculoskeletal abnormalities, cardiac disease, and some immune abnormalities. The challenges of identifying, isolating, differentiating, and expanding these cells has limited widespread adoption to date. Still, Corning is committed to enabling advancement in this important research area. We offer a wide range of platforms and surface technologies to help drive your stem cell therapy research forward, including:
 

  • Pre-coated, high-density vessels for the reproducible expansion of adherent or suspension-based stem cell cultures
  • Customizable closed system options that eliminate open fluid manipulation
  • Specialized, xeno-free surfaces, media, and reagents to address stem cell research, providing you with a single supplier for your work with MSCs, ESCs, iPSCs, and NSCs
  • Customizable options in vessels, surfaces, and media to meet your requirements

Products

Stem Cell Therapy: Featured Products

Featured Technology

Advanced Surfaces at Work

Featured Resources


Stem Cell Therapy Applications

Human bone marrow-derived MSC yields and viability from Corning HYPERStack 36-layer cell culture vessels. Bars are cell density and dots are viability.

Bone Marrow-derived Human Mesenchymal Stem Cell Production in Corning HYPERStack 36-layer Cell Culture Vessels

Review the demonstration of the utility of the Corning HYPERStack 36-layer cell culture vessel as a tool to meet the growing demand for expanding bone marrow-derived MSCs to relevant scale for clinical application workflows.

Learn More

The Growing Role of MSCs in Regenerative Medicine

The Growing Role of MSCs in Regenerative Medicine

Learn more about the growing role of MSCs in regenerative medicine, including current challenges and potential tools and technologies to help overcome them.

Learn More

Clinical Use of hESC-derived Cardiac Progenitors

Clinical Use of hESC-derived Cardiac Progenitors

This paper summarizes the main steps of the translational shift from bench scale methods to a cell-based medicinal product for a first-in-man clinical trial for transplantation of SSEA-1+ progenitors in patients with severely impaired cardiac function. 

Learn More

Support

Field Applications Support

Related Products

You may also be interested in these related products.

HYPERStack®

HYPERStack®

HYPERStack®

Combining the best of two Corning producs-the Corning CellSTACK® culture chamber and HYPERFlask® vessel, the Corning HYPERStack® vessel is the most efficient, scalable vessel for adherent cell culture.

Combining the best of two Corning producs-the Corning CellSTACK® culture chamber and HYPERFlask® vessel, the Corning HYPERStack® vessel is the most efficient, scalable vessel for adherent cell culture.

CellSTACK®

CellSTACK®

CellSTACK®

Choose between Corning CellBIND® surface for enhanced cell attachment or Ultra-Low Attachment surface for improved cell maintenance.

Choose between Corning CellBIND® surface for enhanced cell attachment or Ultra-Low Attachment surface for improved cell maintenance.

HYPERFlask®

HYPERFlask®

HYPERFlask®

This high yield, high performance flask utilizes a multilayered gas permeable growing surface for efficient gas exchange.

This high yield, high performance flask utilizes a multilayered gas permeable growing surface for efficient gas exchange.